| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.17 | 0.004 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.089 | 0.07 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.084 | 0.09 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.083 | 0.1 |